Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
http://clinicaltrials.gov/ct2/show/NCT05158023
Jan 25, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next